Showing results (121-130 of 244) with videos related to

Sort By:
Pageof 25
Oncotarget|October 17, 2015
Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective studyHai-Liang Zhang, Xiao-Jian Qin, Hong-Kai Wang, et al.
Frontiers in Genetics|October 2, 2019
Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical CarcinomaWen-Hao Xu, Junlong Wu, Jun Wang, et al.
Journal of Cellular Biochemistry|December 31, 2019
Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancerWen-Hao Xu, Jun Wang, Hao-Yue Sheng, et al.
The Journal of Urology|March 20, 2012
External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinomaHong-Kai Wang, Yao Zhu, Xu-Dong Yao, et al.
Asian Journal of Andrology|September 17, 2013
Influence of obesity on localized prostate cancer patients treated with radical prostatectomyYuan-Yuan Qu, Bo Dai, Yun-Yi Kong, et al.
Medicine|July 12, 2016
Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patientsCheng-Yuan Gu, Xiao-Jian Qin, Yuan-Yuan Qu, et al.
Oncotarget|May 13, 2015
Prognostic significance of the TREK-1 K2P potassium channels in prostate cancerGui-Ming Zhang, Fang-Ning Wan, Xiao-Jian Qin, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|September 5, 2012
[Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: long-term effects and safety]Yi-jun Shen, Xiao-jie Bian, Hu-yang Xie, et al.
Medicine|February 26, 2015
Use of RENAL nephrometry scores for predicting tumor upgrading between core biopsies and surgical specimens: a prospective ex vivo studyGui-Ming Zhang, Yao Zhu, Hua-Lei Gan, et al.
Asian Journal of Andrology|August 21, 2012
The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?Guo-Wen Lin, Xu-Dong Yao, Ding-Wei Ye, et al.
Pageof 25